Iridex Sees FY2026 Sales $51.000M-$53.000M vs $56.549M Est.

Benzinga Newsdesk www.benzinga.com Positive 73.5%

Neg 0% Neu 0% Pos 73.5%

Iridex (NASDAQ:IRIX) sees FY2026 sales of $51.000 million-$53.000 million vs $56.549 million analyst estimate.

Comments

No comments yet. Be the first!